Acadia Pharmaceuticals Inc. · NASDAQ:ACAD

Schneyer Mark C. sold 2,709 Acadia Pharmaceuticals Inc. shares (Form 4)

Traded Apr 5 to Apr 7, 2026 · Filed Apr 7, 2026

From Apr 5 to Apr 7, 2026, Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) sold 2,709 Acadia Pharmaceuticals Inc. shares at US$22.20 for US$60,140, leaving 62,836 shares. Filed Apr 7, 2026 (Form 4).

Sold
2,709 shares
Price
US$22.20
Value
US$60,140
Holding after
62,836 shares
Trading plan
No
Role
EVP, CHIEF FINANCIAL OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 5, 2026Common StockOption exercise5,27665,545Direct
Apr 7, 2026Common StockSale2,709US$22.2062,836Direct

Source

View original at SEC

Related